Massachusetts’ dynamic life sciences innovation ecosystem thrives on transformative science and powerful partnerships. MassBio convenes, connects, and catalyzes the ecosystem, serving as a platform to source, accelerate, partner, and fund innovation.
Through our various programs, MassBio creates unique opportunities for meaningful connections with key opinion leaders and subject matter experts on a diverse set of topics including academic-industry collaborations, start-ups, partnering, and capital.
For more information, contact the innovation team.
Against the backdrop of the evolving and unpredictable funding landscape, MassBio Align Summit connects investors with the brightest and best startups and small companies in the life sciences. Align Summit 2024 will focus on artificial intelligence and machine learning in drug discovery and development, highlighting emerging companies that focus on AI/ML R&D as well as biotech breakthroughs.
Partnering Events & Pharma Days®
Through unrivaled partnering events, MassBio connects biopharma, medical device, and digital health companies with groundbreaking science or emerging startups for potential collaboration opportunities while helping to grow their brand visibility across MassBio’s robust innovation networks.
Since 2010, MassBio has facilitated more than 1,000 connections between emerging entrepreneurs and established biopharmaceutical companies through Pharma Days® and other partnering initiatives. Recent event hosts include: Novo Nordisk, Otsuka, Sanofi, Daiichi Sankyo, Pfizer, Eli Lilly, Baxter, and more!
Sponsor a partnering event to increase brand awareness, cultivate deep connections, and stand out in your industry.
If you’re an early-stage company or an academic institution looking to explore partnering, licensing, and M&A prospects, check out our upcoming partnering events for 1:1 meeting opportunities.